Normalization of serum free light chains during therapy in the MM5 trial predicts prolonged progression free survival and overall survival

Autor:	Uta Bertsch, Markus Munder, Steffen Luntz, Barbara Hügle-Dörr, Jens Hillengass, Christina Kunz, Britta Besemer, Ahmet H. Elmaagacli, Hans Salwender, Hartmut Goldschmidt, Mathias Haenel, Stephan Fuhrmann, Hans-Walter Lindemann, Igor Wolfgang Blau, Maximilian Merz, Katja Weisel, Axel Benner, Stefanie Huhn, Bernhard Rabold, Elias K. Mai, Thomas Hielscher, Martin Hoffmann, Dirk Hose, Diana Tichy, Eva-Maria Haas, Jan Dürig, Marc S. Raab, Peter Brossart, Helga Bernhard, Anna Jauch, Martin Goerner, Nicola Giessen, Anja Seckinger, Christof Scheid
Jazyk:	angličtina
Rok vydání:	2019
Předmět:	Oncology Normalization (statistics) Cancer Research medicine.medical_specialty business.industry Medizin Hematology Immunoglobulin light chain Serum free Internal medicine medicine Overall survival Progression-free survival business
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f871b92020df6216c19200e22786465 Zobrazit plný text záznamu